Skip to content
10-K

Annual Report

SIGYN THERAPEUTICS, INC. SIGY

0001641172-25-004740

← back to feed
Filed
Apr 15, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Apr 11, 2025 1.61M sh
Shares Diluted FY 2024 · Dec 31, 2024 1.33M sh
Shares Diluted FY 2024 · Dec 31, 2023 1.1M sh
Operating Cash Flow FY 2024 · Dec 31, 2024 −$872.44K
Operating Cash Flow FY 2024 · Dec 31, 2023 −$1.38M
Long Term Debt FY 2024 · Dec 31, 2024 $2.02M
Short Term Debt FY 2024 · Dec 31, 2024 $174.21K
Cash And Equivalents FY 2024 · Dec 31, 2024 $12.14K
Cash And Equivalents FY 2024 · Dec 31, 2023 $11.69K
Stockholders Equity FY 2024 · Dec 31, 2024 −$4.46M
Stockholders Equity FY 2024 · Dec 31, 2023 −$3.41M
Stockholders Equity FY 2024 · Dec 31, 2022 −$1.9M
Current Liabilities FY 2024 · Dec 31, 2024 $4.61M
Current Liabilities FY 2024 · Dec 31, 2023 $3.61M
Total Liabilities FY 2024 · Dec 31, 2024 $4.67M
Total Liabilities FY 2024 · Dec 31, 2023 $3.73M
Current Assets FY 2024 · Dec 31, 2024 $21.24K
Current Assets FY 2024 · Dec 31, 2023 $118.06K
Total Assets FY 2024 · Dec 31, 2024 $213.72K
Total Assets FY 2024 · Dec 31, 2023 $321.81K
Eps Diluted FY 2024 · Dec 31, 2024 −$2.51
Eps Diluted FY 2024 · Dec 31, 2023 −$3.77
Eps Basic FY 2024 · Dec 31, 2024 −$2.51
Eps Basic FY 2024 · Dec 31, 2023 −$3.77
Sga Expense FY 2024 · Dec 31, 2024 $1.74M
Sga Expense FY 2024 · Dec 31, 2023 $1.66M
Rd Expense FY 2024 · Dec 31, 2024 $773.28K
Rd Expense FY 2024 · Dec 31, 2023 $798.17K
Net Income FY 2024 · Dec 31, 2024 −$3.34M
Net Income FY 2024 · Dec 31, 2023 −$4.15M
Operating Income FY 2024 · Dec 31, 2024 −$2.52M
Operating Income FY 2024 · Dec 31, 2023 −$2.46M